Podcast Episodes
Back to SearchDec 18, 2020 This Week in Cardiology Podcast
COVID, sacubitril/valsartan and spironolactone in patients with HFpEF, year-end comments are the topics discussed by John Mandrola, MD in this week's…
5 years, 6 months ago
Dec 11, 2020 This Week in Cardiology Podcast
COVID, the clogged pipe frame of CAD, paclitaxel, and AF performance measures and Goodhart's law are the topics John Mandrola, MD, covers in this wee…
5 years, 6 months ago
Dec 4, 2020 This Week in Cardiology Podcast
COVID vaccines, tocilizumab, finerenone, type 2 MI care, coronary CTA, and sotagliflozin are the topics discussed by John Mandrola, MD, in this week'…
5 years, 6 months ago
Nov 20, 2020 This Week in Cardiology Podcast
COVID-19 vaccines and virtual AHA presentations on statins and the nocebo effect, high dose omega-3s, and AF ablation are the topics John Mandrola, M…
5 years, 7 months ago
Nov 13, 2020 This Week in Cardiology Podcast
COVID19 vaccines, thrombolysis in stroke, industry payments to doctors, and the upcoming AHA are topics covered by John Mandrola, MD, in this week's …
5 years, 7 months ago
Nov 6, 2020 This Week in Cardiology Podcast
COVID, AF ablation, pediatric "do not dos" from AAP, heart failure performance measures, and a brief AHA preview are the topics discussed by John Man…
5 years, 7 months ago
Oct 30, 2020 This Week in Cardiology Podcast
Remdesivir, the athletic heart, troponin and echo abnormalities in patients with COVID-19, and a novel MRA drug are the topics John Mandrola, MD, dis…
5 years, 7 months ago
Oct 23, 2020 This Week in Cardiology Podcast
COVID, tocilizumab, hypertrophic cardiomyopathy, cerebral microbleeds, and surrogate endpoints are the topics discussed by John Mandrola, MD, in this…
5 years, 8 months ago
Oct 16, 2020 This Week in Cardiology Podcast
COVID drug trials and science news, BNP, polypharmacy in heart failure, and in-patient CPR are the topics john Mandrola, MD, discusses in this week's…
5 years, 8 months ago
Oct 9, 2020 This Week in Cardiology Podcast
COVID-19, scientific philosophy, left main coronary artery disease, empagliflozin and the SGLT2 inhibitors are the topics discussed by John Mandrola,…
5 years, 8 months ago